Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium
- 8 March 2021
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 126, 144-153
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 81 references indexed in Scilit:
- Interferon-γ Causes Cardiac Myocyte Atrophy via Selective Degradation of Myosin Heavy Chain in a Model of Chronic MyocarditisThe American Journal of Pathology, 2012
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growthGrowth Factors, 2011
- Controlling nuclear JAKs and STATs for specific gene activation by IFNγBiochemical and Biophysical Research Communications, 2011
- Cardiovascular Complications of Rheumatoid Arthritis: Assessment, Prevention, and TreatmentRheumatic Disease Clinics of North America, 2010
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genesProceedings of the National Academy of Sciences, 2009
- Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytesCardiovascular Research, 2009
- Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle CellsCirculation, 2009
- Interferon-γ Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic MiceThe American Journal of Pathology, 2007